A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia - PubMed (original) (raw)
. 1982 Dec 23;300(5894):765-7.
doi: 10.1038/300765a0.
- PMID: 6960256
- DOI: 10.1038/300765a0
A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia
A de Klein et al. Nature. 1982.
Abstract
The transforming genes of oncogenic retroviruses are homologous to a group of evolutionary conserved cellular onc genes. The human cellular homologue (c-abl) of the transforming sequence of Abelson murine leukaemia virus (A-MuL V) was recently shown to be located on chromosome 9. The long arm of this chromosome is involved in a specific translocation with chromosome 22, the Philadelphia translocation (Ph1), t(9; 22) (q34, q11), which occurs in patients with chronic myelocytic leukaemia (CML)3-5. Here we investigate whether the c-abl gene is included in this translocation. Using c-abl and v-abl hybridization probes on blots of somatic cell hybrids, positive hybridization is found when the 22q- (the Philadelphia chromosome), and not the 9q+ derivative of the translocation, is present in the cell hybrids. From this we conclude that in CML, c-abl sequences are translocated from chromosome 9 to chromosome 22q-. This finding is a direct demonstration of a reciprocal exchange between the two chromosomes and suggests a role for the c-abl gene in the generation of CML.
Similar articles
- Localization of the human c-sis oncogene in Ph1-positive and Ph1-negative chronic myelocytic leukemia by in situ hybridization.
Bartram CR, de Klein A, Hagemeijer A, Grosveld G, Heisterkamp N, Groffen J. Bartram CR, et al. Blood. 1984 Jan;63(1):223-5. Blood. 1984. PMID: 6336312 - Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia.
Bartram CR, de Klein A, Hagemeijer A, van Agthoven T, Geurts van Kessel A, Bootsma D, Grosveld G, Ferguson-Smith MA, Davies T, Stone M, et al. Bartram CR, et al. Nature. 1983 Nov 17-23;306(5940):277-80. doi: 10.1038/306277a0. Nature. 1983. PMID: 6580527 - Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells.
Kozbor D, Giallongo A, Sierzega ME, Konopka JB, Witte ON, Showe LC, Croce CM. Kozbor D, et al. Nature. 1986 Jan 23-29;319(6051):331-3. doi: 10.1038/319331a0. Nature. 1986. PMID: 3455750 - Oncogene activation by chromosomal rearrangement in chronic myelocytic leukemia.
De Klein A. De Klein A. Mutat Res. 1987 Sep;186(2):161-72. doi: 10.1016/0165-1110(87)90029-7. Mutat Res. 1987. PMID: 3306360 Review. - Chronic myelogenous leukemia and genetic events at 9q34.
Lewis JP, Watson-Williams EJ, Lazerson J, Jenks HM. Lewis JP, et al. Hematol Oncol. 1983 Jul-Sep;1(3):269-74. doi: 10.1002/hon.2900010309. Hematol Oncol. 1983. PMID: 6376316 Review.
Cited by
- Human ABL1 deficiency syndrome (HADS) is a recognizable syndrome distinct from ABL1-related congenital heart defects and skeletal malformations syndrome.
AlAbdi L, Neuhann T, Prott EC, Schön U, Abdulwahab F, Faqeih E, Alkuraya FS. AlAbdi L, et al. Hum Genet. 2024 Jun;143(6):739-745. doi: 10.1007/s00439-024-02677-y. Epub 2024 May 14. Hum Genet. 2024. PMID: 38743093 - Aspiring toward equitable benefits from genomic advances to individuals of ancestrally diverse backgrounds.
Wang Y, He Y, Shi Y, Qian DC, Gray KJ, Winn R, Martin AR. Wang Y, et al. Am J Hum Genet. 2024 May 2;111(5):809-824. doi: 10.1016/j.ajhg.2024.04.002. Epub 2024 Apr 19. Am J Hum Genet. 2024. PMID: 38642557 Review. - FL118 Is a Potent Therapeutic Agent against Chronic Myeloid Leukemia Resistant to BCR-ABL Inhibitors through Targeting RNA Helicase DDX5.
Takeda K, Ohta S, Nagao M, Kobayashi E, Tago K, Funakoshi-Tago M. Takeda K, et al. Int J Mol Sci. 2024 Mar 26;25(7):3693. doi: 10.3390/ijms25073693. Int J Mol Sci. 2024. PMID: 38612503 Free PMC article. - ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination.
Jones JK, Zhang H, Lyne AM, Cavalli FMG, Hassen WE, Stevenson K, Kornahrens R, Yang Y, Li S, Dell S, Reitman ZJ, Herndon JE 2nd, Hoj J, Pendergast AM, Thompson EM. Jones JK, et al. Neurooncol Adv. 2023 Aug 7;5(1):vdad095. doi: 10.1093/noajnl/vdad095. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37781087 Free PMC article. - Abl kinases can function as suppressors of tumor progression and metastasis.
Marchal MA, Moose DL, Varzavand A, Jordan NE, Taylor D, Tanas MR, Brown JA, Henry MD, Stipp CS. Marchal MA, et al. Front Oncol. 2023 Sep 8;13:1241056. doi: 10.3389/fonc.2023.1241056. eCollection 2023. Front Oncol. 2023. PMID: 37746268 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous